| Karen Elizabeth Boudet, MSP CF-SLP | |
|
568 Blue Ridge Dr, Evans, GA 30809-3604 | |
| (706) 364-5262 | |
| Not Available |
| Full Name | Karen Elizabeth Boudet |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 568 Blue Ridge Dr, Evans, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326485277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | PCET001891 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Elizabeth Boudet, MSP CF-SLP 550 Ernestine Fls, Grovetown, GA 30813-5516 Ph: (706) 496-0265 | Karen Elizabeth Boudet, MSP CF-SLP 568 Blue Ridge Dr, Evans, GA 30809-3604 Ph: (706) 364-5262 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab (marketed by Genentech/Roche). Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.6 billion.
Ranir, LLC, a leading oral care consumer products company, announced today that it has acquired Synpart Limited and Synpart AG from HemCon Medical Technologies, Inc. Synpart is a leading manufacturer and marketer of store brand oral care products in the European Community and a contract manufacturer for global branded oral care companies.
Scientists are reporting for the first time that previously unrecognized substances released by algae blooms have the potential to act as endocrine disruptors, which can interfere with the normal activity of reproductive hormones. The effect is not caused by microcystin toxins, long recognized as potentially harmful to humans and aquatic animals, but as yet unidentified substances.
Delcath Systems, Inc., a medical technology company developing the Delcath Percutaneous Hepatic Perfusion (PHP(TM)) System, a minimally invasive drug delivery platform for the regional treatment of cancer metastatic to the liver, today reported on the Company's recent progress.
› Verified 2 days ago
Amanda Lynn Hughes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 989 Napiers Post Dr, Evans, GA 30809 Phone: 706-969-6647 | |
Carlos Golston, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4222 Fairfield Cir, Evans, GA 30809 Phone: 706-831-4572 | |
Payton Russell, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 Oakhurst Dr Ste A, Evans, GA 30809 Phone: 706-831-1128 Fax: 770-230-0157 | |
Schitonya K Fleming, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4405 Evans To Locks Rd, Evans, GA 30809 Phone: 706-854-1598 | |
Mackenzie Rosamond Collentine, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 568 Blue Ridge Dr, Evans, GA 30809 Phone: 706-364-5262 | |
Mrs. Hannah Lloyd Ferguson, M.ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 568 Blue Ridge Dr, Evans, GA 30809 Phone: 706-364-5262 | |
Carla M Pennington, M.ED. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 434 Long Needle Cir, Evans, GA 30809 Phone: 706-829-4848 |